The next step in improving (semi-)quantitative MPI PET

Dendritic Cell Immunotherapy, the Next Step in Cancer Treatment

Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...

Dendritic Cell Immunotherapy, the Next Step in Cancer Treatment

Cancer immunotherapy has gained a lot of interest over the past few years due to the success of immune checkpoint inhibitors in treating cancer (1, 2). Immune checkpoint inhibitors, such as monoclonal antibodies against cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1), have been shown to increase survival of patients with advanced cancers (1, 2). These in...

Improving Semi-Quantitative Reasoning by Landmark Approximation

Many extensions to existing qualitative simulation packages allow combined use of available numeric and qualitative information . Some provide numeric integration across two qualitative states but none of them highlights numerically or semi-quantitatively the qualitatively predicted time points . Moreover, high accuracy at time points is only achieved by a fine level of granularity across the e...

dendritic cell immunotherapy, the next step in cancer treatment

na

The next step